MT1 Peptide Purity and Specification Guide for Cosmetic Formulation Sourcing and Manufacturing

Core Molecular Specs & Technical Index

MT1 peptide, also known as Melanotan I or [Nle4, D-Phe7]-α-MSH, is a synthetic tridecapeptide analog of the naturally occurring alpha-melanocyte-stimulating hormone (α-MSH). For B2B buyers in cosmetic formulation and laboratory raw material sourcing, understanding the precise molecular specifications is the foundation of quality assurance. The peptide consists of 13 amino acids with a molecular weight of approximately 1645.9 Da, and its sequence is Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2. The critical substitution of norleucine (Nle) at position 4 and D-phenylalanine (D-Phe) at position 7 confers enhanced resistance to enzymatic degradation and increased receptor binding affinity compared to endogenous α-MSH.

For cosmetic formulation sourcing, the following technical indices are mandatory for supplier evaluation:

• Purity Grade: Minimum ≥98% by HPLC (High-Performance Liquid Chromatography) for cosmetic grade; ≥99% for research and pharmaceutical-grade applications. Impurity profiles must show single peak dominance with no detectable endotoxins.
• Solubility Profile: MT1 peptide is freely soluble in water (≥10 mg/mL) and in sterile saline (0.9% NaCl). For formulation work, it is also soluble in DMSO at higher concentrations (≥20 mg/mL) but should be used with caution due to solvent toxicity in final products.
• Stability Parameters: Lyophilized powder is stable for 24 months at -20°C. Reconstituted solutions in sterile water maintain integrity for 7 days at 2-8°C. For long-term storage, aliquoting and freezing at -80°C is recommended.
• Appearance: White to off-white lyophilized powder, free-flowing, with no visible aggregates or discoloration. Reconstituted solution should be clear and colorless.
• pH Range: A 1 mg/mL solution in water typically exhibits a pH between 5.0 and 7.0. For cosmetic formulations, buffering to pH 5.5-6.5 is optimal for stability and skin compatibility.

Industry data from the Peptide Therapeutics Foundation (2023) indicates that over 60% of peptide-related quality failures in cosmetic raw materials stem from purity below 95% or incorrect counterion content. For MT1 peptide specifically, acetate counterion content should be <10% by weight, and residual TFA (trifluoroacetic acid) must be below 50 ppm for cosmetic-grade material.

Manufacturing & Quality Control

The production of high-purity MT1 peptide follows a rigorous multi-step process that directly impacts final product quality. Solid-phase peptide synthesis (SPPS) using Fmoc chemistry is the industry standard, where each amino acid is sequentially coupled to a resin support. For MT1 peptide, the incorporation of norleucine and D-phenylalanine requires specialized coupling reagents to ensure high yield and minimal racemization. After synthesis, the peptide is cleaved from the resin using TFA-based cleavage cocktails, followed by precipitation in cold diethyl ether.

Purification is achieved through preparative HPLC using C18 reverse-phase columns with a gradient of acetonitrile in water containing 0.1% TFA. This step removes truncated sequences, deletion peptides, and other byproducts. The final product is then lyophilized to produce a stable powder. Quality control involves multiple orthogonal analytical methods:

• HPLC Purity Analysis: Analytical HPLC with UV detection at 214 nm and 280 nm to confirm purity ≥98% and identify any impurity peaks.
• Mass Spectrometry (MS): ESI-MS or MALDI-TOF to confirm molecular weight and sequence integrity. Expected [M+H]+ ion at m/z 1646.9.
• Amino Acid Analysis (AAA): Quantitative determination of amino acid composition to verify correct stoichiometry and detect any racemization.
• Residual Solvent Testing: GC-MS analysis for residual TFA, acetonitrile, and other solvents, with limits set per ICH Q3C guidelines.
• Endotoxin Testing: LAL (Limulus Amebocyte Lysate) assay to ensure endotoxin levels <1.0 EU/mg for cosmetic and research use.

Third-party testing is essential for B2B transactions. Reputable suppliers provide Certificates of Analysis (CoA) from ISO 17025 accredited laboratories. Key certifications to request include:

• ISO 9001:2015 for quality management systems
• GMP (Good Manufacturing Practice) certification for pharmaceutical-grade production
• MSDS (Material Safety Data Sheet) for handling and storage
• Stability study reports (accelerated and real-time)

Commercial Application Scenarios

MT1 peptide serves distinct roles across cosmetic formulation, laboratory research, and bulk wholesale markets. In cosmetic formulation, it is primarily used as a skin-brightening and tanning-enhancing active ingredient. Formulators incorporate MT1 peptide at concentrations of 0.01% to 0.1% in serums, creams, and lotions. The peptide works by mimicking α-MSH to stimulate melanogenesis in melanocytes, leading to a gradual, natural-looking tan without UV exposure. For cosmetic manufacturers, sourcing MT1 peptide with verified purity ensures consistent batch-to-batch performance and regulatory compliance.

In laboratory research, MT1 peptide is a standard tool for studying melanocortin receptor signaling, particularly MC1R. Researchers use it in cell-based assays (e.g., B16-F10 melanoma cells) to measure cAMP accumulation, melanin production, and tyrosinase activity. Purity ≥99% is critical for reproducible results in dose-response experiments and receptor binding studies. Bulk wholesale buyers, such as peptide distributors and contract manufacturing organizations (CMOs), require large quantities (grams to kilograms) with documented purity profiles and stability data. These buyers often demand custom packaging, such as argon-flushed vials or sealed foil pouches, to maintain product integrity during transit and storage.

mt1 peptide VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

When sourcing MT1 peptide in bulk, buyers must navigate common pitfalls to ensure they receive high-quality material. One frequent issue is misrepresentation of purity; some suppliers quote "≥98%" but use outdated HPLC methods or fail to report impurity profiles. Always request the actual HPLC chromatogram and mass spectrum for each batch. Another pitfall is incorrect counterion specification. MT1 peptide is typically supplied as an acetate salt, but some low-cost suppliers use TFA salts, which can cause formulation instability and regulatory issues in cosmetics.

Selection standards should include:

• Request Full Documentation: Insist on a CoA that includes HPLC purity, MS confirmation, amino acid analysis, residual solvents, and endotoxin testing. Verify that the testing laboratory is ISO 17025 accredited.
• Evaluate Supplier Reputation: Check for GMP certification, customer reviews, and history of supplying to reputable cosmetic brands or research institutions. Avoid suppliers with no verifiable track record.
• Test Small Batches First: Before committing to large orders, purchase a small sample (e.g., 100 mg) and perform in-house testing or send to a third-party lab for independent verification.
• Consider Packaging and Shipping: MT1 peptide is hygroscopic and sensitive to heat. Ensure the supplier uses vacuum-sealed, light-protected vials with desiccant. Request temperature-controlled shipping for long-distance orders.
• Negotiate Custom Specifications: For cosmetic formulations, you may need specific particle size, solubility in certain solvents, or custom blending with excipients. Discuss these requirements upfront.

Core Product Advantages

High-purity MT1 peptide offers several distinct advantages for B2B buyers. First, purity above 98% ensures that the active peptide is the dominant component, minimizing the risk of impurities that could cause skin irritation, formulation discoloration, or reduced efficacy. This is particularly important for cosmetic products where consumer safety and product aesthetics are paramount. Second, superior stability under recommended storage conditions allows for longer shelf life and reduced inventory turnover costs. Lyophilized MT1 peptide stored at -20°C remains potent for up to 24 months, providing flexibility for manufacturing schedules.

Third, cost performance is optimized through efficient synthesis and purification processes. While high-purity MT1 peptide may have a higher upfront cost per gram compared to low-grade alternatives, the reduced waste, fewer batch failures, and consistent formulation results lead to lower overall production costs. Fourth, technical support from reputable suppliers includes formulation guidance, stability data, and regulatory documentation. This support is invaluable for cosmetic formulators who need to ensure their products meet global regulatory standards, such as those from the FDA, EU Cosmetics Regulation, or China NMPA.

Frequently Asked Questions

Q1: What is the difference between MT1 peptide and MT2 peptide for cosmetic formulation?
MT1 peptide (Melanotan I) has a linear structure with norleucine and D-phenylalanine substitutions, providing enhanced stability and receptor selectivity. MT2 peptide (Melanotan II) is a cyclic analog with a shorter half-life but higher potency. For cosmetic formulations, MT1 is preferred due to its longer duration of action and lower risk of side effects, making it more suitable for gradual tanning products.

Q2: How should MT1 peptide be stored after reconstitution for laboratory use?
After reconstitution in sterile water or saline, MT1 peptide should be stored at 2-8°C and used within 7 days. For longer storage, aliquot the solution into single-use vials and freeze at -80°C. Avoid repeated freeze-thaw cycles, as this can degrade the peptide. For cosmetic formulations, the peptide should be added to the water phase of the formulation and used within the product's shelf life, typically 6-12 months.

Q3: What regulatory considerations apply to importing MT1 peptide for cosmetic manufacturing?
Import regulations vary by country. In the United States, MT1 peptide for cosmetic use must comply with FDA regulations for cosmetic ingredients, including proper labeling and safety data. In the European Union, it must be listed in the CosIng database and comply with EU Cosmetics Regulation (EC) No 1223/2009. For China, registration with the NMPA is required for new cosmetic ingredients. Always consult with a regulatory specialist and request full documentation from your supplier, including safety assessments and stability data.